Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
514345, 514351, 514408, 514438, 514456, 514657, 546290, 546296, 546300, 548517, 548518, 548557, 548558, 548564, 548566, 548579, 549 74, 549358, 549362, 549429, 549491, 558411, 564316, 564323, 564336, 564344, 564366, A61K 31135
Compounds of the formula ##STR1## and pharmaceutically acceptable salt thereof, wherein R.sup.2 is selected from hydroxy and lower alkoxy, R.sup.5 is lower alkyl, and R.sup.11 and R.sup.12 are independently selected from hydrogen, halo, hydroxy, methoxy, and lower alkyl, are selective .alpha..sub.2 adrenergic receptor antagonists useful in the treatment of glaucoma.
patent: 3419560 (1968-12-01), Bernstein et al.
Basha Fatima Z.
DeBernardis John F.
Zelle Robert E.
Crowley Steven R.
Hollrah Glennon N.
Janssen Jerry F.
1-aminomethyl-1,2,3,4-tetrahydronaphthalenes does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with 1-aminomethyl-1,2,3,4-tetrahydronaphthalenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-aminomethyl-1,2,3,4-tetrahydronaphthalenes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-348257